Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olmesartan + amlodipine versus perindopril + amlodipine in diabetic patients with essential hypertension
2010-018774-21Phase 3Completed
- Sponsor
- Menarini Group
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of olmesartan, amlodipine and perindopril in essential hypertension (2 arms), sponsored by Menarini Group. Started May 2010; status: completed.
02
Drugs
olmesartanamlodipineperindopril
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2010-018774-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018774-21.